Application and validation of PFGE for serovar identification of Leptospira clinical isolates.

Serovar identification of clinical isolates of Leptospira is generally not performed on a routine basis, yet the identity of an infecting serovar is valuable from both epidemiologic and public health standpoints. Only a small number of reference laboratories worldwide have the capability to perform...

Full description

Bibliographic Details
Main Authors: Renee L Galloway, Paul N Levett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC2939049?pdf=render
id doaj-de3578fee99e44cf94a38cd8e988a4a1
record_format Article
spelling doaj-de3578fee99e44cf94a38cd8e988a4a12020-11-25T02:29:27ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27352010-01-0149e100088810.1371/journal.pntd.0000824Application and validation of PFGE for serovar identification of Leptospira clinical isolates.Renee L GallowayPaul N LevettSerovar identification of clinical isolates of Leptospira is generally not performed on a routine basis, yet the identity of an infecting serovar is valuable from both epidemiologic and public health standpoints. Only a small number of reference laboratories worldwide have the capability to perform the cross agglutinin absorption test (CAAT), the reference method for serovar identification. Pulsed-field gel electrophoresis (PFGE) is an alternative method to CAAT that facilitates rapid identification of leptospires to the serovar level. We employed PFGE to evaluate 175 isolates obtained from humans and animals submitted to the Centers for Disease Control and Prevention (CDC) between 1993 and 2007. PFGE patterns for each isolate were generated using the NotI restriction enzyme and compared to a reference database consisting of more than 200 reference strains. Of the 175 clinical isolates evaluated, 136 (78%) were identified to the serovar level by the database, and an additional 27 isolates (15%) have been identified as probable new serovars. The remaining isolates yet to be identified are either not represented in the database or require further study to determine whether or not they also represent new serovars. PFGE proved to be a useful tool for serovar identification of clinical isolates of known serovars from different geographic regions and a variety of different hosts and for recognizing potential new serovars.http://europepmc.org/articles/PMC2939049?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Renee L Galloway
Paul N Levett
spellingShingle Renee L Galloway
Paul N Levett
Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
PLoS Neglected Tropical Diseases
author_facet Renee L Galloway
Paul N Levett
author_sort Renee L Galloway
title Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
title_short Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
title_full Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
title_fullStr Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
title_full_unstemmed Application and validation of PFGE for serovar identification of Leptospira clinical isolates.
title_sort application and validation of pfge for serovar identification of leptospira clinical isolates.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2735
publishDate 2010-01-01
description Serovar identification of clinical isolates of Leptospira is generally not performed on a routine basis, yet the identity of an infecting serovar is valuable from both epidemiologic and public health standpoints. Only a small number of reference laboratories worldwide have the capability to perform the cross agglutinin absorption test (CAAT), the reference method for serovar identification. Pulsed-field gel electrophoresis (PFGE) is an alternative method to CAAT that facilitates rapid identification of leptospires to the serovar level. We employed PFGE to evaluate 175 isolates obtained from humans and animals submitted to the Centers for Disease Control and Prevention (CDC) between 1993 and 2007. PFGE patterns for each isolate were generated using the NotI restriction enzyme and compared to a reference database consisting of more than 200 reference strains. Of the 175 clinical isolates evaluated, 136 (78%) were identified to the serovar level by the database, and an additional 27 isolates (15%) have been identified as probable new serovars. The remaining isolates yet to be identified are either not represented in the database or require further study to determine whether or not they also represent new serovars. PFGE proved to be a useful tool for serovar identification of clinical isolates of known serovars from different geographic regions and a variety of different hosts and for recognizing potential new serovars.
url http://europepmc.org/articles/PMC2939049?pdf=render
work_keys_str_mv AT reneelgalloway applicationandvalidationofpfgeforserovaridentificationofleptospiraclinicalisolates
AT paulnlevett applicationandvalidationofpfgeforserovaridentificationofleptospiraclinicalisolates
_version_ 1724833058761211904